Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PRME.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 95.07M
March 31, 2026 135.50M
December 31, 2025 177.68M
September 30, 2025 213.29M
June 30, 2025 101.75M
March 31, 2025 144.26M
December 31, 2024 190.44M
September 30, 2024 175.53M
June 30, 2024 162.87M
March 31, 2024 210.72M
December 31, 2023 121.66M
September 30, 2023 165.32M
Date Value
June 30, 2023 207.62M
March 31, 2023 249.52M
December 31, 2022 293.92M
September 30, 2022 146.66M
June 30, 2022 180.60M
March 31, 2022 211.27M
December 31, 2021 269.62M
September 30, 2021 299.92M
June 30, 2021
March 31, 2021
December 31, 2020 53.33M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. 1.153B
Twist Bioscience Corp. 166.84M
Sana Biotechnology, Inc. 164.68M
Intellia Therapeutics, Inc. 437.76M
Revolution Medicines, Inc. 3.938B